May 12, 2021
Global sale of Celltrion's COVID-19 antibody-drug Regkirona begins
Global sale of Celltrion’s COVID-19 antibody-drug Regkirona begins
Image Source : PTI Global sale of Celltrion’s COVID-19 antibody-drug Regkirona begins Worldwide sales of Regkirona (active ingredient: regdanvimab), a COVID-19 antibody drug developed by South Korean biopharmaceutical company Celltrion Inc, has begun. Celltrion Healthcare Co Ltd, the marketing arm of Celltrion, announced on Monday that it has signed a contract with a Pakistani state-owned…
View On WordPress